Masahiro Toda
Affiliations: | Keio University, Minato-ku, Tōkyō-to, Japan |
Area:
Neuro-oncologyGoogle:
"Masahiro Toda"Mean distance: 16.88 (cluster 17)
Parents
Sign in to add mentor| Keiichi Uyemura | grad student | Keio University | |
| Robert L. Martuza | post-doc | Georgetown |
Children
Sign in to add trainee| Yohei Ohashi | research assistant | 2000-2004 | Keio University |
| Yukihiko Iizuka | grad student | 1997-2004 | Keio University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Morimoto Y, Tokumitsu A, Sone T, et al. (2022) TPT1 Supports Proliferation of Neural Stem/Progenitor Cells and Brain Tumor Initiating Cells Regulated by Macrophage Migration Inhibitory Factor (MIF). Neurochemical Research |
| Tamura R, Morimoto Y, Sato M, et al. (2020) A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma. Vaccines. 8 |
| Tamura R, Fujioka M, Morimoto Y, et al. (2020) Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nature Communications. 11: 2028 |
| Tamura R, Morimoto Y, Kosugi K, et al. (2020) Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series. Bmc Cancer. 20: 301 |
| Tamura R, Morimoto Y, Kosugi K, et al. (2020) Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series. Bmc Cancer. 20: 196 |
| Kamamoto D, Kanazawa T, Ishihara E, et al. (2020) Efficacy of a topical gelatin-thrombin hemostatic matrix, FLOSEAL, in intracranial tumor resection. Surgical Neurology International. 11: 16 |
| Tamura R, Sato M, Morimoto Y, et al. (2020) Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors. Experimental and Molecular Pathology. 114: 104408 |
| Tamura R, Miyoshi H, Morimoto Y, et al. (2020) Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect. Human Gene Therapy |
| Tamura R, Morimoto Y, Sato M, et al. (2020) Difference in the hypoxic immunosuppressive microenvironment of patients with neurofibromatosis type 2 schwannomas and sporadic schwannomas. Journal of Neuro-Oncology |
| Tamura R, Fujioka M, Morimoto Y, et al. (2019) A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nature Communications. 10: 5758 |